Mirjana Huic

Learn More
OBJECTIVE We assessed the adequacy of randomized controlled trial (RCT) registration, changes to registration data and reporting completeness for articles in ICMJE journals during 2.5 years after registration requirement policy. METHODS For a set of 149 reports of 152 RCTs with ClinicalTrials.gov registration number, published from September 2005 to April(More)
and Sports project 'Influence of a science journal on the Croatian medical community' Abstract Scholarly journals, especially in non-English-speaking countries, may perform very different functions depending on whether they are published for national or international audiences. A total of 466 academic physicians and non-academic general practitioners in(More)
The Croatian Medical Journal (CMJ) is a bimonthly scientific journal, that publishes mostly original articles. It is indexed in the Index Medicus/MEDLINE, Current Contents/Clinical Medicine, and the Science Citation Index Expanded. Since the CMJ's 15th anniversary in 2007, our aim has been to assess the importance of the Journal through its impact factor(More)
The opportunity cost of inappropriate health policy decisions is greater in Central and Eastern European (CEE) compared with Western European (WE) countries because of poorer population health and more limited healthcare resources. Application of health technology assessment (HTA) prior to healthcare financing decisions can improve the allocative efficiency(More)
INTRODUCTION Tobacco smoking claims 700,000 lives every year in Europe and the cost of tobacco smoking in the EU is estimated between €98 and €130 billion annually; direct medical care costs and indirect costs such as workday losses each represent half of this amount. Policymakers all across Europe are in need of bespoke information on the economic and(More)
AIM To determine the effect of aminoglycoside cycling in six tertiary intensive care units (ICU) on the rates of sepsis, aminoglycoside resistance patterns, antibiotic consumption, and costs. METHODS This was a prospective longitudinal interventional study that measured the effect of change from first-line gentamicin usage (February 2002-February 2003) to(More)
OBJECTIVES High-quality clinical evidence is most often lacking when novel high-risk devices enter the European market. At the same time, a randomized controlled trial (RCT) is often initiated as a requirement for obtaining market access in the US. Should coverage in Europe be postponed until RCT data are available? We studied the premarket clinical(More)
The European network for Health Technology Assessment (EU-netHTA) was established to increase cooperation in European health technology assessment (HTA) by developing a common set of tools, methods, documents, and HTA information. The collaboration is well recognized within the European HTA community and at an international level. Timely and efficient usage(More)
  • 1